AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06737276 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interactive fiction activities
Description: The case studies were prepared using interactive fiction through Twine. Each case simulated a nursing consultation with a patient requiring dietary advice, and the patient's evolution depended on the students' choices. All cases created had similar structures, durations, and difficulties to avoid complexity-related bias. For each circumstance, three possible dietary advice options were offered to the patient: one option that would be ideal, one suitable option, and one unsuitable option.
Study NCT06737276 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Role-play simulation
Description: Role-play activity of the nursing consultation on dietary advice according to Nemec et al. (2021) recommendations. Ten case studies of a nursing consultation on dietary advice involving a nurse and a patient were designed with the consensus of a group of nursing professionals with expertise in food and nutrition, health literacy, and communication. Each student was assigned a role and provided with the necessary information to play their character or understand their patient's context. The information provided was different according to the role assigned. They had to perform a simulation of eight minutes, similar to the time available in the student's primary care consultations in the referral health system. Thus, the patient and the family member had to explain the situation or health problem, the professional would analyse it, and together, they would try to reach a therapeutic agreement. After the consultation, a debriefing was carried out.
Study NCT06741033 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy of medial knee osteoarthritis patients: Isometric exercises, strengthening exercises, stretching exercises and electrotherapy.
Study NCT06741033 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Toe-in gait modification
Description: A specific alteration in walking pattern where the toes are directed inward during walking. This modification should be clearly defined, including the degree of inward rotation of the foot and how it is taught and monitored in participants. Toe-in gait modification basically includes decrease foot progression angle from baseline through internal foot rotation. Participants are instructed to increase the Toe-in angle of their study limb by 5 degree and walk at least 5-10 minutes (progressed to 15-20 min after 4 week) with this progression angle.
Study NCT04904042 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of plasma of neutral argon
Description: Evaluation of the mesentery or peritoneum area infiltrated by miliary implants that is going to be treated. Determination of the PCI. Collection of several samples of the mesenteric peritoneum or parietal peritoneum with tumor involvement (implants between 1-2.5mm of diameter).~It will established a matrix which will be divided into 12 quadrants where the tissue with implants will be placed and it will be treated according to specific power (80-100%), and for an action time of 2-4 seconds or until macroscopic tumor destruction. For each power, application of Plasmajet at 1, 2 and 3 cm from the target tumor tissue.~The in-vivo effect will be evaluated with the use of ball-tip in terms of damage to the serosa or vascularization of the mesentery.
Study NCT05661136 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Warm air blower
Description: Lower body blanket with warm air blower set at 44 deg c started after spinal anesthesia when patient placed in supine/left lat position
Study NCT05661136 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control: Lower body blanket not attached to warm air blower
Description: Control: Lower body blanket placed, not attached to warm air blower
Study NCT06359249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: change of habits
Description: change of habits
Study NCT06359249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: change of habits + auto abdominal massage
Description: change of habits + auto abdominal massage
Study NCT04245124 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strategic Memory Advanced Reasoning Training
Description: SMART focuses on three metacognitive strategies: Strategic Attention, Integrated Reasoning and Innovation.
Study NCT04245124 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Cognitive Rehabilitation
Description: Participants randomized to the TCR condition will participate in a clinician-directed intervention that provides manualized, traditional clinician-directed cognitive rehabilitation that was developed for the SCORE trial (Cooper et al., 2017)
Study NCT05014074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theater/Pilot Testing
Description: Participants will take part in a theater/pilot testing in order to receive adequate feedback and make substantive change in the intervention
Study NCT05636085 — intervention group
Intervention type: DEVICE
Intervention: Mainz Biomed Colorectal Cancer Screening Test
Description: There is no intervention.
Study NCT06367153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1569912
Description: BI 1569912
Study NCT06367153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: repaglinide
Description: repaglinide
Study NCT06367153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: midazolam
Description: midazolam
Study NCT06367153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bupropion
Description: bupropion
Study NCT04901026 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: An in-house manikin
Description: Participants obtain an in-house manikin
Study NCT04901026 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: An in-house manikin
Description: Participants obtain an in-house manikin
Study NCT04645797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APR003
Description: This portion of the study further explores the clinical activity, safety, pharmacokinetics and pharmacology of APR003 monotherapy at the RP2D and to assess the antitumor activity of APR003 in subjects with unresectable CRC with liver metastases.
Study NCT05882006 — intervention group
Intervention type: OTHER
Intervention: gallstones
Description: fellow up if the patients have gallstones
Study NCT04869124 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin
Description: Dapagliflozin propanediol (FORXIGA) tablet: 10 mg once daily p.o. on top of recommended standard therapy, duration of administration: 12 weeks.
Study NCT04869124 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet, matching Dapagliflozin, once daily p.o. on top of recommended standard therapy, duration of administration: 12 weeks.
Study NCT05978414 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visceral therapy
Description: Visceral therapy will be performed manually by a physiotherapist, a detailed description of the techniques is above. Therapy will be in 2 subgroups with prolapse of the usual genitals and endometriosis.
Study NCT05978414 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be in 2 subgroups that will not have visceral therapy. The placebo will consist of the physiotherapist holding hands on the patient's pelvis.
Study NCT06158477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JYP0035 Experimental Drug Treatment
Description: Single dose intervention
Study NCT06741150 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NWRD09 administered by intramuscular injection
Description: Intramuscular injection administration was carried out according to the protocol design.
Study NCT06403345 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Green Activity Program
Description: See arm description.
Study NCT06566196 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardiac Cath
Description: Patient will undergo standard of care Cardiac Cath and in addition invasive CPET (Cardiopulmonary exercise testing) will be performed during the procedure.
Study NCT06272058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avenciguat (BI 685509)
Description: Avenciguat (BI 685509)
Study NCT04729478 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Drug-induced sleep endoscopy
Description: An intravenous bolus injection of midazolam 1.5 mg will be used to induce sleep. Maintenance of sedated sleep will be obtained by a target-controlled infusion of propofol (2.0-3.0 µg/mL).
Study NCT04729478 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Natural sleep endoscopy
Description: Endoscopy during natural sleep.
Study NCT05956184 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intrauterine Device Insertion
Description: All womens will be placed in a gynecological position and underwent a bimanual examination to better determine whether the uterus was in the anteverted or retroverted position. Subsequently, a speculum will be inserted, and the cervix will be disinfected with betadine. In the conventional method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and after entering the uterine cavity with a hysterometry the IUD is inserted. In the direct method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and without using hysterometry the IUD is directly inserted. The strings will be cut approximately 2-3 cm after the cervix, and the Pozzi forceps and speculum will be removed. The accuracy of the IUD placement will be confirmed using pelvic ultrasound. The process will take about five minutes.
Study NCT04628832 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PMP Use Mandate Letter
Description: A letter with reminders about the mandate to check the PMP when prescribing opioids.
Study NCT04628832 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prescribing Information Letter
Description: A letter with information about the prescriber's patients who received co-prescriptions. The letters will provide clinical background on the harms of co-prescribing and encourage prescribers to avoid co-prescribing in the future.
Study NCT04628832 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prescribing Information + PMP Use Mandate Letter
Description: A letter combining the content of the PMP Use Mandate Letter and the Prescribing Information Letter. This letter will remind prescribers about the PMP use mandate and provide information about the prescriber's patients who received co-prescriptions.
Study NCT06739174 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Confidence Be 1-Piece Closed Bag
Description: Active Chamber Filter - Circle Shape
Study NCT06739174 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Confidence Natural 1-Piece Closed Bag
Description: Protective Filter - Circle Shape
Study NCT05587998 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Participants will receive IV dose of Morphine as stated in arm description.
Study NCT05587998 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Morphine
Description: Participants will receive IV dose of Morphine as stated in arm description.
Study NCT05587998 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD4041
Description: Participants will receive oral doses of AZD4041 as stated in arm description.
Study NCT05587998 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive oral doses of placebo as stated in arm description.
Study NCT04906187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Arm A : intraoperative ANI monitoring of nociception
Description: For the experimental group (arm A), the sufentanil doses are adjusted to maintain an ANI between 50 and 70. Morphine doses are adjusted from 0.05 to 0.05 µg / ml. Intraoperative data will be collected for ANI, TIVA and hemodynamics.
Study NCT04906187 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Arm B : no specific monitoring of nociception
Description: For the control group (arm B), adjustments to the opioid doses are made in relation to the hemodynamic reactions of the patient and the operating times. Intraoperative data will be collected for TIVA and hemodynamics.
Study NCT05459935 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBM Tonsil Arm
Description: exposure of hypertrophic tonsils to photobiomodulation
Study NCT06739174 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Confidence Be go 1-Piece Closed Bag
Description: Active Chamber Filter - Hexagon Shape
Study NCT06741020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab, Oxaliplatin, Fluorouracil,Leucovorin
Description: Chemotherapy drugs including Oxaliplatin, Fluorouracil,Leucovorin and immunotherapy durgs Adebrelimab will infuse to liver by transarterial catheter toward to the lesion.
Study NCT05726058 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: XyCAM with oxygen
Description: After the standard imaging protocols, participants will be asked to inhale 100% oxygen through a mask and will be re-imaged using the XyCAM RI or XyCAM FC.
Study NCT05459935 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham PBM Tonsil Arm
Description: non-powered exposure of hypertrophic tonsils to photobiomodulation
Study NCT04284436 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treadmill walking
Description: Treadmill walking 4 days per week for 30 minutes in the target heart rate
Study NCT04284436 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treadmill walking
Description: Treadmill walking 4 days per week for 30 minutes in the target heart rate
Study NCT06736665 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Orbital atherectomy
Description: The Diamondback-360 (OAS) (Abbott) device is used to perform this technique, consisting of a bidirectional, diamond-coated orbital crown that utilizes a combination of centrifugal force (creating elliptical orbits) and surface abrasion to modify the calcified plaque and increase distensibility. Additionally, the pulsatile impact of the crown at high speed can create microfractures in deep calcium. As a result, a single 1.25 mm crown can treat vessels ranging from 2.5 to 4 mm in diameter.
Study NCT06736665 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intravascular lithotripsy
Description: The Shockwave Medical Intravascular Lithotripsy System (Shockwave Medical) is a balloon that emits pulsatile sonic waves capable of fracturing intracoronary calcium. This therapy is administered by advancing a catheter and inflating the balloon at low pressure to deliver sonic pulses.
Study NCT06736665 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Optical Coherence Tomography (OCT)
Description: Optical Coherence Tomography (OCT) is an intravascular imaging modality that uses near-infrared light to provide high-definition, cross-sectional and three-dimensional images of the vessel microstructure.~These images provide additional information on the degree and characteristics of coronary artery disease compared to angiography which doesn't delineate the composition of the coronary artery. With automated, highly accurate measurements, OCT can guide stent selection, placement, and deployment.
Study NCT06736665 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous coronary intervention with stent implantation
Description: All patients will undergo percutaneous coronary intervention with drug-eluting stent implantation after plaque modification using the technique assigned by randomization.
Study NCT06739447 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consumer Wearable Device Vital Sign Measurement
Description: Consumer Wearable Devices such as the Fitbit, are durable devices that can provide vital sign data.
Study NCT06738186 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video-based exercise program
Description: The video-based exercise program - Bliib fit -mach mit! focuses on mobilization, muscle strengthening (focus on lower and upper extremities), coordination, balance, and relaxation. Each participant requires the use of a chair for support and to perform exercises in a seated position, if required. The group sessions are supervised by a care professional or registered activation specialist of the residential care facility.
Study NCT06738186 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Caregiver-led activation program
Description: The caregiver-led activation program (DESKK- Demenzspezifisches Kurzzeitpflegekonzept) is instructed and carried out by care professionals (e.g., nursing staff) as optimized standard care conducted individually or in groups.
Study NCT06739135 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual feedback training
Description: Visual feedback training to modify use of the accelerator pedal when driving in a driving simulator, to reduce the % of time driving with the pedal pushed down more than 9 degrees
Study NCT06739317 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Subjects receive Stereotactic Body Radiotherapy combined with Camrelizumab and Apatinib as conversion therapy.
Study NCT06739317 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: First line therapy
Description: Subjects receive Camrelizumab intravenously. Subjects receive Apatinib orally.
Study NCT06739317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: First line therapy
Description: Subjects receive Camrelizumab intravenously. Subjects receive Apatinib orally.
Study NCT06739317 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: operation
Description: If subjects suitable for hepatic resection after conversion therapy, radical surgery and postoperative adjuvant therapy will be performed.
Study NCT06740292 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: conventional miniplates
Description: conventional miniplates in double configuration
Study NCT06740292 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InterFlex plates
Description: InterFlex plates in configuration
Study NCT06738212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group A aerobic exercises
Description: Group A will perform the aerobic exercises (such as bicycling, treadmill and running) Aerobic exercises 15min/session for each exercise, 2 times/week. Frequency: 2 times /week Intensity: Easy to moderate about 60 to 75% of maximum heart rate Type: treadmill, bicycling, running Time: 45min/session~Bicycling:~15~- Start with gentle, low-intensity cycling and gradually increase as comfort allows - Aim for regular, consistent cycling sessions (e.g., 2-3 times a week,15min/session) - Consider incorporating other exercises, like stretching or yoga, to complement cycling.~Running~To get started with running for dysmenorrhea:~1. Start with short distances and gradually increase as comfort allows~2. Aim for regular, consistent running sessions (e.g., 2-3 times a week,15 minute/session)~3. Consider incorporating other exercises, like stretching or yoga, to complement running.
Study NCT06738212 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group B Aviva exercises
Description: Group B will perform the Aviva exercises in 18 different movements. Aviva exercise intervention method is based on a carefully structured, mild-to-moderate intensity series of 18 movement sequences and aerobic exercises 30min/session, 2 times/week (20)~Aviva Methods of exercises:~These exercises are a carefully structured, intense, and methodical series of movement sequences, including a 5 min warm-up exercise at the beginning and 5 min cooling-down exercises at the end of the session. These exercises are performed in Standing, Sitting, Supine lying, prone lying
Study NCT06741293 — intervention group
Intervention type: OTHER
Intervention: No intervention: observational study
Description: No intervention: observational study
Study NCT06739148 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy
Description: Low-level laser therapy can increase cellular energy production, making it useful as a pre-conditioning treatment to prevent muscle contraction fatigue or as a post-contraction therapy to accelerate fatigue recovery.
Study NCT06739148 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: blood flow restriction
Description: Its advantage is that during training, it can surpass the \&#34;overload principle,\&#34; allowing for effective muscle cross-sectional area growth with relatively light weight training (20%-50% of 1RM or 20%-40% of MVC).
Study NCT06739148 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation
Description: It is a strength training method that uses electrical currents to stimulate nerve and muscle activation, helping to maintain muscle mass, increase blood flow, and slow down or prevent muscle atrophy.
Study NCT06486805 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N acetyl cysteine
Description: N-acetylcysteine (NAC) is a small molecule containing a thiol (sulfhydryl-containing) group, which has antioxidant properties and is freely filterable, thus making it readily accessible to the intracellular compartment
Study NCT05730608 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 18F-FDG PET/CT
Description: Included breast cancer patients will undergo a 18F-FDG PET/CT scan in addition to conventional imaging with CT and bone scintigraphy.
Study NCT05102201 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paro (social robot) intervention
Description: Participants in the Paro group will receive a group (6-8 people as a group), facilitated, and 30-minute weekly session Paro intervention for 6 weeks